Published in J Clin Pathol on February 01, 1984
Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer (1986) 1.91
Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis. Br J Cancer (1986) 1.45
Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA. Br J Cancer (1986) 1.44
Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol (2005) 1.32
Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br J Cancer (1991) 1.25
The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med (2013) 1.21
Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9. Br J Cancer (1989) 1.18
Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer. Br J Cancer (1994) 1.11
The MUC gene family: their role in diagnosis and early detection of pancreatic cancer. Mol Cancer (2003) 1.06
AB0 blood group and prognosis in patients with pancreatic cancer. BMC Cancer (2012) 1.06
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. Br J Cancer (1994) 1.03
CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone. Br J Cancer (2009) 0.98
Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases. Br J Cancer (1987) 0.95
Markers of bile duct tumors. World J Gastrointest Oncol (2011) 0.90
Elevated serum level of carbohydrate antigen 19-9 in benign biliary stricture diseases can reduce its value as a tumor marker. Int J Clin Exp Med (2014) 0.87
The molecular targets for the diagnosis and treatment of pancreatic cancer. Gut Liver (2010) 0.82
Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma. Br J Cancer (1991) 0.80
Carbohydrate antigen 19-9 as a serum marker of hepatocellular carcinoma: comparison with alpha-foetoprotein. Br J Cancer (1987) 0.79
An evaluation of DUPAN-2 in pancreatic cancer and gastrointestinal disease. Br J Cancer (1990) 0.78
Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma. BMC Genomics (2015) 0.77
Organ Specific Tumor Markers: What's New? Indian J Clin Biochem (2011) 0.77
History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer. Surg Today (2017) 0.76
Serum increase and liver overexpression of carbohydrate 19.9 antigen in patients with genetic haemochromatosis. Gut (1994) 0.76
Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9. J Clin Pathol (1987) 0.76
Immunohistochemical Cal9-9 in primary colonic polyps and polyps synchronous with colorectal cancer. Gut (1987) 0.75
Gemcitabine-Based Regional Intra-Arterial Infusion Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma. Medicine (Baltimore) (2016) 0.75
RCAS1, a useful serum marker to predict the recurrence of cancer: two cases of cholangiocarcinoma and pancreatic cancer. Dig Dis Sci (2004) 0.75
Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet (1979) 7.28
Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem (1983) 3.91
Specific antigen in serum of patients with colon carcinoma. Science (1981) 3.68
Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res (1982) 2.21
alpha-Fetoprotein in cancer and fetal development. Adv Cancer Res (1979) 2.16
A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science (1981) 2.02
Studies of carcino-fetal proteins. 3. Development of a radioimmunoassay for -fetoprotein. Demonstration of -fetoprotein in serum of healthy human adults. Int J Cancer (1971) 1.97
Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization. Cancer (1978) 1.84
A reappraisal of the value of carcinoembryonic antigen in the management of patients with various neoplasms. Br J Surg (1979) 1.21
Oncofetal antigens. Increasing the specificity of the CEA radioimmunoassay. Am J Clin Pathol (1977) 0.99
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet (1997) 7.59
AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa. N Engl J Med (1986) 4.68
Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer (2000) 4.55
Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet (1992) 4.54
Fibronectin binds to Staphylococcus aureus. Nature (1978) 4.39
Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer (1998) 3.98
Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci U S A (1999) 3.77
Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis (1989) 3.67
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology (1991) 3.38
Separation of normal and immune lymphoid cells by antigen-coated coated columns. Antigen-binding characteristics of membrane antibodies as analyzed by hapten-protein antigens. J Exp Med (1970) 3.08
Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res (1997) 2.99
Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development (2000) 2.82
Effect of the number of haptens coupled to each erythrocyte on haemolytic plaque formation. Immunology (1969) 2.71
Fibroblast surface antigen: a new serum protein. Biochim Biophys Acta (1973) 2.71
The role of cell number and source in adoptive immunity. Immunology (1965) 2.68
The effect of antigen dosage on the response of adoptively transferred cells. Immunology (1965) 2.59
In vivo nuclear transport kinetics in Saccharomyces cerevisiae: a role for heat shock protein 70 during targeting and translocation. J Cell Biol (1996) 2.33
Inherited immunoglobulin idiotypes of the mouse. Immunol Rev (1977) 2.29
Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol (2003) 2.23
Bacterial plasminogen activators and receptors. FEMS Microbiol Rev (2001) 2.19
Hydrophobic domains affect the collagen-binding specificity and surface polymerization as well as the virulence potential of the YadA protein of Yersinia enterocolitica. Mol Microbiol (1993) 2.13
Variants of hepatic arterial supply in a Caribbean population: a computed tomography based study. Clin Radiol (2013) 2.13
Demonstration of an intracellular copper-binding protein by orcein staining in long-standing cholestatic liver diseases. Gut (1976) 2.09
Binding of human fibronectin to group A, C, and G streptococci. Infect Immun (1983) 2.01
Prognosis of severe brain injury. Acta Neurol Scand (1970) 1.98
Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa. Gut (1988) 1.98
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organelles. Mol Microbiol (1990) 1.94
Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer (1986) 1.91
Soluble antigen-antibody complexes and platelet aggregation. Acta Pathol Microbiol Scand (1969) 1.91
Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer (1985) 1.89
The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol (1989) 1.87
Attachment of staphylococci and streptococci on fibronectin, fibronectin fragments, and fibrinogen bound to a solid phase. Infect Immun (1985) 1.86
Nucleus-vacuole junctions in Saccharomyces cerevisiae are formed through the direct interaction of Vac8p with Nvj1p. Mol Biol Cell (2000) 1.86
Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization. Cancer (1978) 1.84
Inheritance of antibody specificity. I. Anti-(4-hydroxy-3-nitrophenyl)acetyl of the mouse primary response. J Exp Med (1974) 1.82
Saccharomyces cerevisiae Nip7p is required for efficient 60S ribosome subunit biogenesis. Mol Cell Biol (1997) 1.76
A very large PC LAN as the basis for a hospital information system. J Med Syst (1991) 1.76
Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland) Cancer Causes Control (2000) 1.75
Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy. Arch Surg (2000) 1.71
Strain differences in the fine specificity of mouse anti-hapten antibodies. Eur J Immunol (1973) 1.69
Adhesion protein YadA of Yersinia species mediates binding of bacteria to fibronectin. Infect Immun (1992) 1.66
Congenital nephrotic syndrome (NPHS1): features resulting from different mutations in Finnish patients. Kidney Int (2000) 1.65
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping. Thorax (1998) 1.64
Isolated hapten-binding receptors of sensitized lymphocytes. I. Receptors from nylon wool-enriched mouse T lymphocytes lack serological markers of immunoglobulin constant domains but express heavy chain variable portions. Eur J Immunol (1977) 1.61
Management of congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol (1995) 1.58
Silver-stained structures (AgNORs), their dependence on tissue fixation and absence of prognostic relevance in rectal adenocarcinoma. J Pathol (1989) 1.57
Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer (1984) 1.56
Functional mapping of the Yersinia enterocolitica adhesin YadA. Identification Of eight NSVAIG - S motifs in the amino-terminal half of the protein involved in collagen binding. Mol Microbiol (2000) 1.55
The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol (1992) 1.55
Gastric metaplasia and chronic inflammation at the duodenal bulb mucosa. Dig Liver Dis (2003) 1.55
Purification and characterisation of a plasmin-sensitive surface protein of Staphylococcus aureus. Eur J Biochem (1996) 1.54
The diversity and specialization of immunocytes. Prog Allergy (1970) 1.54
Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand J Gastroenterol (1991) 1.53
Anti-oxazolone hybridomas and the structure of the oxazolone idiotype. J Immunol (1983) 1.52
Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol (1996) 1.48
Gastric cancer associated structure in mucus glycoproteins shown as a clinically useful marker. Gut (1991) 1.48
Assay of anti-hapten antibody with the aid of hapten-coupled bacteriophage. Immunology (1966) 1.48
Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma. Acta Pathol Microbiol Scand A (1980) 1.47
Is Mycoplasma hominis a vaginal pathogen? Sex Transm Infect (2001) 1.46
Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia. Am J Gastroenterol (2001) 1.45
Apoptosis in different compartments of antrum and corpus mucosa in chronic Helicobacter pylori gastritis. An 18-year follow-up study. Scand J Gastroenterol (2001) 1.45
Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double blind placebo-controlled study in children. Pediatr Infect Dis J (1994) 1.44
Immunological interspecies cross-reactions of fibroblast surface antigen (fibronectin). Immunochemistry (1976) 1.44
The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer. Br J Cancer (1994) 1.44
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Follow-up of Helicobacter pylori positive gastritis and argyrophil cells pattern during the natural course of gastric ulcer. Helicobacter (1998) 1.41
Characteristics and outcome of acute infection with hepatitis B virus in children with cancer. Pediatr Infect Dis J (1991) 1.41
Binding sites for streptococci and staphylococci in fibronectin. Infect Immun (1984) 1.41
Diagnosis of fetal submicroscopic chromosomal abnormalities in failed array CGH samples: copy number by sequencing as an alternative to microarrays for invasive fetal testing. Ultrasound Obstet Gynecol (2015) 1.41
Fine-needle aspiration biopsy allows early detection of acute rejection in children after renal transplantation. Transplantation (2001) 1.39
Association between diaphragm use and urinary tract infection. JAMA (1985) 1.38
The four subclasses of IgG can be isolated from mouse serum by using Protein A-Sepharose. Scand J Immunol (1981) 1.37
Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample. Cancer (1983) 1.36
Isolation of a tryptic fragment containing the collagen-binding site of plasma fibronectin. J Biol Chem (1979) 1.35
Determination of 19S and 7S components in an anti-hapten antibody. Ann Med Exp Biol Fenn (1967) 1.34
Affinity requirements for antibody assays mapped by monoclonal antibodies. J Immunol (1983) 1.33
Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology (2002) 1.31
Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer (2003) 1.30
Serum CA 50 as a tumor marker in pancreatic cancer: a comparison with CA 19-9. Int J Cancer (1987) 1.30
Gastric polyps; their morphological and endoscopical characteristics and relation to gastric carcinoma. Acta Pathol Microbiol Immunol Scand A (1982) 1.29
Analogies between lymphocyte receptors and the resulting humoral antibodies. Transplant Rev (1970) 1.29
A mendelian idiotype is demonstrable in the heteroclitic anti-NP antibodies of the mouse. Eur J Immunol (1978) 1.29
Fecal bacteriology and reservoir ileitis in patients operated on for ulcerative colitis. Dis Colon Rectum (1988) 1.29
Single lymph node cells producing heteroclitic bacteriophage antibody. J Immunol (1965) 1.28
Demonstration of fibronectin in human cerebrospinal fluid. J Lab Clin Med (1978) 1.28
Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion (2000) 1.27
Effect of Pseudomonas aeruginosa rhamnolipids on mucociliary transport and ciliary beating. J Appl Physiol (1985) (1992) 1.27